 <h1>Gardasil 9 Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>human papillomavirus vaccine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about human papillomavirus vaccine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Gardasil 9.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to human papillomavirus vaccine: intramuscular suspension</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, human papillomavirus vaccine (the active ingredient contained in Gardasil 9) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking human papillomavirus vaccine:</p><p>
<i>Less common</i>
</p><ul>
<li>Fever</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Anxiety</li>
<li>back, leg, or stomach pains</li>
<li>bleeding gums</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>dark urine</li>
<li>difficulty with breathing</li>
<li>difficulty with swallowing</li>
<li>dizziness or lightheadedness</li>
<li>fainting</li>
<li>fast heartbeat</li>
<li>general body swelling</li>
<li>headache</li>
<li>hives or welts, itching, or skin rash</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>nosebleeds</li>
<li>pale skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>seizures</li>
<li>sore throat</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of human papillomavirus vaccine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Pain, redness, itching, or swelling at the injection site</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bleeding, bruising, or lumps at the injection site</li>
<li>diarrhea</li>
<li>difficulty with moving</li>
<li>joint pain or swelling</li>
<li>muscle ache, cramps, pain, or stiffness</li>
<li>upper abdominal or stomach pain</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, numbness, rash, redness, scarring, soreness, stinging, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>body aches or pain</li>
<li>ear congestion</li>
<li>loss of voice</li>
<li>sneezing</li>
<li>stuffy or runny nose</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating</li>
<li>constipation</li>
<li>dark urine</li>
<li>difficulty with moving</li>
<li>indigestion</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
</ul><p>
<!-- end intramuscular suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to human papillomavirus vaccine: intramuscular suspension</i></p><h3>General</h3><p>The most common adverse events were injection site reactions, fatigue, headache, and myalgia.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (91.9%), injection site swelling (49%), injection site erythema (48.4%)</p>
<p><b>Common</b> (1% to 10%): Injection site pruritus, injection site hematoma, injection site induration, injection site hemorrhage, injection site warmth, injection site mass, injection site reaction</p>
<p><b>Postmarketing reports</b>: Injection site cellulitis<sup>[Ref]</sup></p><h3>Other</h3><p>Deaths occurred during clinical trials which were generally assessed as not vaccine related: car accidents, suicides, acute lymphocytic leukemia, hypovolemic septic shock, airplane crash, cerebral hemorrhage, gunshot wound, stomach adenocarcinoma, pulmonary embolus/deep vein thrombosis, sepsis, pancreatic cancer, arrhythmia, pulmonary tuberculosis, hyperthyroidism, post-operative pulmonary embolism and acute renal failure, traumatic brain injury/cardiac arrest, systemic lupus erythematosus, cerebrovascular accident, breast cancer, nasopharyngeal cancer, autoimmune disease, infectious disease, homicide, and 1 unexplained sudden death 678 days following the last vaccine dose.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Fatigue (54.6%), headache (53.4%), pyrexia (13%), fever of 99.5F or higher (12.9%)</p>
<p><b>Common</b> (1% to 10%): Chlamydia infection, malaise</p>
<p><b>Uncommon</b> (0.1% to 1%): Death</p>
<p><b>Postmarketing reports</b>: Asthenia, chills<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myalgia (48.8%), arthralgia (20.7%)</p>
<p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Postmarketing reports</b>: Pain in extremity<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, vomiting, abdominal pain upper, toothache</p>
<p><b>Rare</b> (less than 0.1%): Appendicitis, gastroenteritis</p>
<p><b>Postmarketing reports</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, oropharyngeal pain, influenza, cough, nasal congestion, upper respiratory tract infection, pharyngitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Pneumonia, pulmonary embolism, asthma</p>
<p><b>Very rare</b> (less than 0.01%): Bronchospasm</p>
<p><b>Frequency not reported</b>: Asthmatic crisis</p>
<p><b>Postmarketing reports</b>: Pulmonary embolus<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, migraine</p>
<p><b>Postmarketing reports</b>: Acute disseminated encephalomyelitis, Guillain-Barre syndrome, motor neuron disease, paralysis, seizures, syncope (including syncope associated with tonic-clonic movements and other seizure-like activity) sometimes resulting in falling with injury, transverse myelitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p>New medical conditions potentially indicative of systemic autoimmune disorders included: arthralgia/arthritis/arthropathy, autoimmune thyroiditis, celiac disease, diabetes mellitus insulin dependent, erythema nodosum, hyperthyroidism, hypothyroidism, inflammatory bowel disease, multiple sclerosis, nephritis, optic neuritis, pigmentation disorder, psoriasis, Raynaud's phenomenon, rheumatoid arthritis, scleroderma/morphea, Stevens-Johnson syndrome, systemic lupus erythematosus, uveitis, alopecia areata, ankylosing spondylitis, autoimmune thrombocytopenia, myocarditis, proteinuria, skin depigmentation, dermatomyositis, vasculitis, and vitiligo.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): New medical conditions potentially indicative of systemic autoimmune disorders</p>
<p><b>Postmarketing reports</b>: Autoimmune diseases<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Injection site hypersensitivity</p>
<p><b>Frequency not reported</b>: Allergy to vaccine</p>
<p><b>Postmarketing reports</b>: Hypersensitivity reactions (including anaphylactic/anaphylactoid reactions, bronchospasm, and urticaria)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lymphadenopathy</p>
<p><b>Postmarketing reports</b>: Autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysmenorrhea, vaginal infection, urinary tract infection</p>
<p><b>Rare</b> (less than 0.1%): Pelvic inflammatory disease, pyelonephritis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, urticaria, itching/pruritus</p>
<p><b>Postmarketing reports</b>: Cellulitis, angioedema, erythema multiforme<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Deep vein thrombosis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Cervarix (human papillomavirus vaccine)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck &amp; Company Inc, Whitehouse Station, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Gardasil (human papillomavirus vaccine)." Merck &amp; Company Inc, West Point, PA. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Gardasil 9 (human papillomavirus vaccine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>30 Reviews</li>
<li>Drug class: viral vaccines</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gardasil 9 &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Gardasil Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Cervarix</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Human Papillomavirus Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to human papillomavirus vaccine: intramuscular suspension</i></p><h3>General</h3><p>The most common adverse events were injection site reactions, fatigue, headache, and myalgia.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (91.9%), injection site swelling (49%), injection site erythema (48.4%)</p><p><b>Common</b> (1% to 10%): Injection site pruritus, injection site hematoma, injection site induration, injection site hemorrhage, injection site warmth, injection site mass, injection site reaction</p><p><b>Postmarketing reports</b>: Injection site cellulitis<sup>[Ref]</sup></p><h3>Other</h3><p>Deaths occurred during clinical trials which were generally assessed as not vaccine related: car accidents, suicides, acute lymphocytic leukemia, hypovolemic septic shock, airplane crash, cerebral hemorrhage, gunshot wound, stomach adenocarcinoma, pulmonary embolus/deep vein thrombosis, sepsis, pancreatic cancer, arrhythmia, pulmonary tuberculosis, hyperthyroidism, post-operative pulmonary embolism and acute renal failure, traumatic brain injury/cardiac arrest, systemic lupus erythematosus, cerebrovascular accident, breast cancer, nasopharyngeal cancer, autoimmune disease, infectious disease, homicide, and 1 unexplained sudden death 678 days following the last vaccine dose.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Fatigue (54.6%), headache (53.4%), pyrexia (13%), fever of 99.5F or higher (12.9%)</p><p><b>Common</b> (1% to 10%): Chlamydia infection, malaise</p><p><b>Uncommon</b> (0.1% to 1%): Death</p><p><b>Postmarketing reports</b>: Asthenia, chills<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myalgia (48.8%), arthralgia (20.7%)</p><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Postmarketing reports</b>: Pain in extremity<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, vomiting, abdominal pain upper, toothache</p><p><b>Rare</b> (less than 0.1%): Appendicitis, gastroenteritis</p><p><b>Postmarketing reports</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, oropharyngeal pain, influenza, cough, nasal congestion, upper respiratory tract infection, pharyngitis</p><p><b>Rare</b> (0.01% to 0.1%): Pneumonia, pulmonary embolism, asthma</p><p><b>Very rare</b> (less than 0.01%): Bronchospasm</p><p><b>Frequency not reported</b>: Asthmatic crisis</p><p><b>Postmarketing reports</b>: Pulmonary embolus<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, migraine</p><p><b>Postmarketing reports</b>: Acute disseminated encephalomyelitis, Guillain-Barre syndrome, motor neuron disease, paralysis, seizures, syncope (including syncope associated with tonic-clonic movements and other seizure-like activity) sometimes resulting in falling with injury, transverse myelitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p>New medical conditions potentially indicative of systemic autoimmune disorders included: arthralgia/arthritis/arthropathy, autoimmune thyroiditis, celiac disease, diabetes mellitus insulin dependent, erythema nodosum, hyperthyroidism, hypothyroidism, inflammatory bowel disease, multiple sclerosis, nephritis, optic neuritis, pigmentation disorder, psoriasis, Raynaud's phenomenon, rheumatoid arthritis, scleroderma/morphea, Stevens-Johnson syndrome, systemic lupus erythematosus, uveitis, alopecia areata, ankylosing spondylitis, autoimmune thrombocytopenia, myocarditis, proteinuria, skin depigmentation, dermatomyositis, vasculitis, and vitiligo.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): New medical conditions potentially indicative of systemic autoimmune disorders</p><p><b>Postmarketing reports</b>: Autoimmune diseases<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Injection site hypersensitivity</p><p><b>Frequency not reported</b>: Allergy to vaccine</p><p><b>Postmarketing reports</b>: Hypersensitivity reactions (including anaphylactic/anaphylactoid reactions, bronchospasm, and urticaria)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lymphadenopathy</p><p><b>Postmarketing reports</b>: Autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysmenorrhea, vaginal infection, urinary tract infection</p><p><b>Rare</b> (less than 0.1%): Pelvic inflammatory disease, pyelonephritis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, urticaria, itching/pruritus</p><p><b>Postmarketing reports</b>: Cellulitis, angioedema, erythema multiforme<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Deep vein thrombosis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Cervarix (human papillomavirus vaccine)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck &amp; Company Inc, Whitehouse Station, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Gardasil (human papillomavirus vaccine)." Merck &amp; Company Inc, West Point, PA. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Gardasil 9 (human papillomavirus vaccine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>30 Reviews</li>
<li>Drug class: viral vaccines</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gardasil 9 &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Gardasil Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Human Papillomavirus Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>